Problem: What are the limitations of peptide-based synthetic pulmonary surfactant built around surfactant protein B (SP-B) and C (SP-C) peptide in neonatal pulmonary medicine especially when Combining nCPAP to improve respiratory outcomes for preterm infants? Need Assignment Help?